Yasufumi Masaki Selected Research

Yasufumi Masaki Research Topics

Disease

15	Immunoglobulin G4-Related Disease 12/2021 - 12/2009
14	Lymphoma (Lymphomas) 03/2022 - 06/2003
13	Neoplasms (Cancer) 05/2022 - 05/2002
11	Fever (Fevers) 05/2022 - 06/2009
11	Multi-centric Castleman's Disease 05/2022 - 04/2010
10	Thrombocytopenia (Thrombopenia) 05/2022 - 10/2010
9	Edema (Dropsy) 05/2022 - 01/2013
7	Fibrosis (Cirrhosis) 05/2022 - 11/2010
7	Castleman Disease (Castleman's Disease) 03/2022 - 12/2009
7	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 08/2003
7	Multiple Myeloma 05/2018 - 08/2009
5	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 07/2008
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2004 - 05/2002
4	Primary Myelofibrosis (Myelosclerosis) 08/2021 - 12/2017
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 02/2021 - 08/2003
3	Renal Insufficiency (Renal Failure) 10/2019 - 01/2018
3	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 12/2017 - 04/2004
3	Disease Progression 07/2014 - 09/2010
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2012 - 08/2009
3	Pancreatitis 01/2011 - 12/2009
3	Rheumatoid Arthritis 10/2007 - 05/2002
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2022 - 04/2012
2	Inflammation (Inflammations) 01/2021 - 01/2013
2	Anemia 01/2019 - 12/2017
2	Ascites 05/2018 - 01/2013
2	Splenomegaly 12/2017 - 02/2014
2	T-Cell Lymphoma (Lymphoma, T Cell) 12/2017 - 02/2006
2	Body Weight (Weight, Body) 09/2017 - 01/2012
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 09/2015 - 05/2011
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2014 - 01/2010
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2011 - 12/2009
2	Sarcoidosis (Schaumann Disease) 01/2011 - 12/2009
2	Sepsis (Septicemia) 07/2010 - 08/2009
2	Lymphadenopathy 04/2010 - 12/2009
2	Leukemia 07/2009 - 06/2003
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2008 - 03/2007
2	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2007 - 02/2003
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2003 - 08/2002
1	Extranodal NK-T-Cell Lymphoma 10/2022
1	Brain Diseases (Brain Disorder) 05/2022
1	Drug-Related Side Effects and Adverse Reactions 05/2022
1	Bites and Stings (Sting) 05/2022
1	Philadelphia Chromosome 05/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2022
1	cell-associated neurotoxicity 05/2022
1	Agraphia (Dysgraphia) 05/2022
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 12/2021

Drug/Important Bio-Agent (IBA)

16	Immunoglobulin G (IgG)IBA 12/2021 - 01/2006
11	Rituximab (Mabthera)FDA Link 02/2021 - 01/2008
9	Reticulin (Reticular Fiber)IBA 05/2022 - 01/2013
8	Interleukin-6 (Interleukin 6)IBA 03/2022 - 04/2010
7	Bortezomib (Velcade)FDA Link 05/2018 - 08/2009
7	Dexamethasone (Maxidex)FDA LinkGeneric 05/2018 - 08/2009
6	Proteins (Proteins, Gene)FDA Link 12/2021 - 05/2002
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 10/2010
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2013
5	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 01/2013
5	Prednisolone (Predate)FDA LinkGeneric 01/2020 - 09/2010
5	GlucocorticoidsIBA 05/2018 - 12/2009
4	C-Reactive ProteinIBA 07/2022 - 01/2013
4	CytokinesIBA 01/2021 - 05/2012
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 02/2006
4	SteroidsIBA 05/2020 - 01/2013
4	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2018 - 01/2006
3	AnthracyclinesIBA 10/2022 - 04/2012
3	Immunoglobulins (Immunoglobulin)IBA 12/2021 - 07/2009
3	Prednisone (Sone)FDA LinkGeneric 01/2021 - 01/2017
3	RNA (Ribonucleic Acid)IBA 05/2020 - 02/2006
3	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 05/2002
3	AntigensIBA 01/2018 - 03/2007
3	Etoposide (VP 16)FDA LinkGeneric 12/2017 - 02/2005
2	AntibodiesIBA 05/2022 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 12/2017
2	Immunoglobulin Fab FragmentsIBA 01/2018 - 10/2010
2	Anaplastic Lymphoma KinaseIBA 12/2017 - 04/2004
2	tocilizumab (atlizumab)FDA Link 06/2016 - 01/2013
2	LeptinIBA 02/2014 - 01/2012
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2012 - 02/2003
2	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2012 - 08/2009
2	ParaffinIBA 02/2006 - 08/2003
1	CholesterolIBA 07/2022
1	AlbuminsIBA 07/2022
1	blinatumomabIBA 05/2022
1	Chimeric Antigen ReceptorsIBA 05/2022
1	Busulfan (Busulfex)FDA Link 03/2022
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 03/2022
1	Antineoplastic Agents (Antineoplastics)IBA 03/2022
1	aziridine (ethyleneimine)IBA 03/2022
1	Alkylating AgentsIBA 03/2022
1	ClusterinIBA 12/2021
1	Blood Proteins (Serum Proteins)IBA 12/2021
1	SilverIBA 12/2021
1	Leucine (L-Leucine)FDA Link 12/2021
1	fibrin fragment D (D-dimer)IBA 08/2021

Therapy/Procedure

24	Therapeutics 10/2022 - 02/2003
18	Drug Therapy (Chemotherapy) 05/2022 - 05/2002
2	Hematopoietic Stem Cell Transplantation 03/2022 - 09/2005
2	Remission Induction 04/2012 - 05/2011
2	Oral Administration 08/2009 - 02/2005
1	Radioimmunotherapy 02/2021